- Home
- GCEngine platform
- Solution
- Partners & Collaborations
- Company
Our mammalian ncAA incorporation service is built for comparability and confirmation. We start with well-controlled assay design (±ncAA, ±aaRS/tRNA and swap controls), run transfection matrices with harmonized plate-reader and/or imaging readouts, and deliver reproducible metrics. Mass-spectrometric confirmation (intact mass and LC–MS/MS) is performed at predefined milestones. From there, we can extend into functional assays or stable-line development with SOP-style guidance. (Research use only; non-GMP.)
Compared with microbial systems, mammalian cells offer physiologically relevant processing but present unique challenges: transfection variability, ncAA uptake/stability, eRF1-driven termination, codon-context effects, and nonsense-mediated mRNA decay (NMD) around re-assigned stop codons. A structured plan—covering vector design, promoter/tRNA copy number, delivery, feeding schedules, and quantitative readouts—enables credible evaluation of readthrough efficiency (RRE) and fidelity, with mass spectrometry serving as the gold‑standard confirmation of site‑specific incorporation and occupancy.
Our company provides a mammalian ncAA incorporation service built for comparability and confirmation. From control-rich assay design through transfection matrices and harmonized readouts, we run the work and deliver reproducible resolutions. The service emphasizes rigorous controls and mass-spectrometric verification of site-specific incorporation and site occupancy, carrying forward into functional assays or stable-line development with clear, practical guidance and credible timelines.
Cell Line & Reporter Setup
Transfection & Expression Optimization
Orthogonal Pair & tRNA Engineering
ncAA Compatibility & Feeding Strategy
Fidelity & Background Analysis
Transfer to Functional Assays or Stable Lines
Bring ncAA functionality into mammalian systems with confidence. Share your cell line, target protein, codon strategy, and timing; we will return a customized plan covering assay design, transfection matrix, feeding schedules, and optional MS confirmation, Contact us with a formal quote. Book a discovery call to establish reproducible data and a credible bridge to downstream studies.
A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.